Insiders · Profile

Soffer Gad

EVP & Chief Strategy Officer at Atara Biotherapeutics. Filing since 17 Aug 2015. CIK 0001612090

Company
Date
Role
Action
Shares
Amount
Of holding
17 Nov 2017
EVP & Chief Strategy Officer
Sold, plan not stated
7,000
$105.00K
2.7%
16 Aug 2017
EVP & Chief Strategy Officer
Sold, plan not stated
2,464
$35.80K
0.9%
15 Aug 2017
EVP & Chief Strategy Officer
Sold, plan not stated
7,000
$105.00K
2.6%
16 May 2017
EVP & Chief Strategy Officer
Sold, plan not stated
5,674
$86.19K
2.1%
15 May 2017
EVP & Chief Strategy Officer
Sold, plan not stated
7,000
$105.91K
2.6%
10 Mar 2017
EVP & Chief Strategy Officer
Sold, plan not stated
2,500
$50.00K
0.9%
16 Feb 2017
EVP & Chief Strategy Officer
Sold, plan not stated
7,273
$113.60K
2.6%
14 Feb 2017
EVP & Chief Strategy Officer
Sold, plan not stated
7,000
$106.54K
2.6%
10 Feb 2017
EVP & Chief Strategy Officer
Sold, plan not stated
6,274
$97.03K
2.3%
17 Nov 2016
Chief Operating Officer
Sold, plan not stated
1,480
$27.25K
0.6%
16 Nov 2016
Chief Operating Officer
Sold, plan not stated
7,136
$137.51K
3.0%
14 Nov 2016
Chief Operating Officer
Sold, plan not stated
9,582
$196.91K
4.1%
16 Aug 2016
Chief Operating Officer
Sold, plan not stated
5,356
$120.04K
3.6%
17 May 2016
Chief Operating Officer
Sold, plan not stated
5,427
$86.34K
3.8%
17 Feb 2016
Chief Operating Officer
Sold, plan not stated
5,711
$95.79K
4.3%
17 Nov 2015
Chief Operating Officer
Sold, plan not stated
7,586
$236.85K
9.5%
18 Aug 2015
Chief Operating Officer
Sold, plan not stated
7,711
$381.63K
10.5%
17 Aug 2015
Chief Operating Officer
Sold, plan not stated
8,778
$438.90K
10.7%
18 decisions on file.